• Saved

Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study - PubMed

Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33523233/

doi: 10.1093/jnci/djab004. Online ahead of print. 1 University of Pittsburgh Medical Center, Hillman Cancer Center/Magee Women's Hospital, Pittsburgh, PA. 2 Genentech, Inc., South San Francisco, CA. 3 Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Victoria, Australia. 4 Department of Medicine, University of California San Francisco, San Francisco, CA.